<?xml version="1.0" encoding="UTF-8"?>
  	<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"><url>
      <loc>https://www.urologytimes.com/view/how-sexual-interest-shapes-post-treatment-bother-in-localized-prostate-cancer</loc><lastmod>2026-05-20T20:57:24.385Z</lastmod><news:news><news:publication_date>2026-05-20T20:57:24.385Z</news:publication_date>
        <news:title><![CDATA[How sexual interest shapes post-treatment bother in localized prostate cancer]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.urologytimes.com/view/sarah-psutka-md-on-the-importance-of-frailty-assessment-in-urologic-oncology</loc><lastmod>2026-05-20T17:30:00Z</lastmod><news:news><news:publication_date>2026-05-20T17:30:00Z</news:publication_date>
        <news:title><![CDATA[Sarah P. Psutka, MD, MSc, on the importance of frailty assessment in urologic oncology]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.urologytimes.com/view/fda-grants-breakthrough-device-designation-to-vesta-bladder-risk-stratify-dx</loc><lastmod>2026-05-20T15:31:27.038Z</lastmod><news:news><news:publication_date>2026-05-20T15:31:27.038Z</news:publication_date>
        <news:title><![CDATA[FDA grants breakthrough device designation to Vesta Bladder Risk Stratify Dx]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.urologytimes.com/view/fda-to-review-sbla-for-nogapendekin-alfa-inbakicept-for-bcg-unresponsive-papillary-nmibc</loc><lastmod>2026-05-20T13:15:32.609Z</lastmod><news:news><news:publication_date>2026-05-20T13:15:32.609Z</news:publication_date>
        <news:title><![CDATA[FDA to review sBLA for nogapendekin alfa inbakicept for BCG-unresponsive papillary NMIBC]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.urologytimes.com/view/setting-the-stage-ai-prognostication-after-radical-prostatectomy</loc><lastmod>2026-05-20T12:00:00Z</lastmod><news:news><news:publication_date>2026-05-20T12:00:00Z</news:publication_date>
        <news:title><![CDATA[Setting the Stage: AI Prognostication After Radical Prostatectomy]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.urologytimes.com/view/pembrolizumab-plus-bcg-elicits-high-cr-rate-in-bcg-na-ve-very-high-risk-t1-nmibc</loc><lastmod>2026-05-19T19:35:53.249Z</lastmod><news:news><news:publication_date>2026-05-19T19:35:53.249Z</news:publication_date>
        <news:title><![CDATA[Pembrolizumab plus BCG elicits high CR rate in BCG-naïve very high-risk T1 NMIBC]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.urologytimes.com/view/rana-r-mckay-md-fasco-details-arasec-findings-in-mhspc</loc><lastmod>2026-05-19T17:35:28.645Z</lastmod><news:news><news:publication_date>2026-05-19T17:35:28.645Z</news:publication_date>
        <news:title><![CDATA[Rana R. McKay, MD, FASCO, details ARASEC findings in mHSPC]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.urologytimes.com/view/real-world-darol-data-support-darolutamide-use-regardless-of-comorbidity-burden</loc><lastmod>2026-05-19T16:45:59.342Z</lastmod><news:news><news:publication_date>2026-05-19T16:45:59.342Z</news:publication_date>
        <news:title><![CDATA[Real-world DAROL data support darolutamide use regardless of comorbidity burden]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.urologytimes.com/view/considerations-and-best-practices-when-using-the-prostatic-urethral-lift</loc><lastmod>2026-05-19T12:00:00Z</lastmod><news:news><news:publication_date>2026-05-19T12:00:00Z</news:publication_date>
        <news:title><![CDATA[Considerations and Best Practices When Using the Prostatic Urethral Lift]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.urologytimes.com/view/enzalutamide-plus-leuprolide-yields-longest-treatment-break-in-embark-analysis</loc><lastmod>2026-05-18T16:06:21.874Z</lastmod><news:news><news:publication_date>2026-05-18T16:06:21.874Z</news:publication_date>
        <news:title><![CDATA[Enzalutamide plus leuprolide yields longest treatment break in EMBARK analysis]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.urologytimes.com/view/phase-1-2-trial-evaluates-recombinant-bcg-in-bcg-na-ve-nmibc</loc><lastmod>2026-05-18T12:00:00Z</lastmod><news:news><news:publication_date>2026-05-18T12:00:00Z</news:publication_date>
        <news:title><![CDATA[Phase 1/2 trial evaluates recombinant BCG in BCG-naïve NMIBC]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.urologytimes.com/view/break-wave-lithotripsy-meets-both-co-primary-end-points-in-sound-trial</loc><lastmod>2026-05-18T11:08:47.652Z</lastmod><news:news><news:publication_date>2026-05-18T11:08:47.652Z</news:publication_date>
        <news:title><![CDATA[Break Wave lithotripsy meets both co-primary end points in SOUND trial]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.urologytimes.com/view/triple-therapy-and-treatment-sequencing-in-mhspc-what-arasec-adds-to-the-conversation</loc><lastmod>2026-05-18T03:10:24.697Z</lastmod><news:news><news:publication_date>2026-05-18T03:10:24.697Z</news:publication_date>
        <news:title><![CDATA[Triple therapy and treatment sequencing in mHSPC: What ARASEC adds to the conversation]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.urologytimes.com/view/urology-workforce-stable-but-facing-access-and-pipeline-challenges-aua-census-finds</loc><lastmod>2026-05-17T18:28:37.283Z</lastmod><news:news><news:publication_date>2026-05-17T18:28:37.283Z</news:publication_date>
        <news:title><![CDATA[Urology workforce stable but facing access and pipeline challenges, AUA Census finds]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.urologytimes.com/view/implantable-tibial-nerve-stimulation-outperforms-sham-in-intibia-pivotal-trial</loc><lastmod>2026-05-17T17:30:00Z</lastmod><news:news><news:publication_date>2026-05-17T17:30:00Z</news:publication_date>
        <news:title><![CDATA[Implantable tibial nerve stimulation outperforms sham in INTIBIA Pivotal Trial]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.urologytimes.com/view/detalimogene-voraplasmid-shows-promising-activity-in-bcg-unresponsive-nmibc</loc><lastmod>2026-05-17T16:14:04.981Z</lastmod><news:news><news:publication_date>2026-05-17T16:14:04.981Z</news:publication_date>
        <news:title><![CDATA[Detalimogene voraplasmid shows promising activity in BCG-unresponsive NMIBC]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.urologytimes.com/view/chad-reichard-md-on-re-induction-with-nadofaragene-in-nmibc</loc><lastmod>2026-05-17T13:30:00Z</lastmod><news:news><news:publication_date>2026-05-17T13:30:00Z</news:publication_date>
        <news:title><![CDATA[Chad Reichard, MD, on re-induction with nadofaragene in NMIBC]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.urologytimes.com/view/phase-2-arasec-data-add-us-population-evidence-for-darolutamide-in-mhspc</loc><lastmod>2026-05-16T20:21:23.083Z</lastmod><news:news><news:publication_date>2026-05-16T20:21:23.083Z</news:publication_date>
        <news:title><![CDATA[Phase 2 ARASEC data add US population evidence for darolutamide in mHSPC]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.urologytimes.com/view/aglatimagene-plus-radiotherapy-improves-prostate-cancer-specific-dfs</loc><lastmod>2026-05-16T18:19:43.654Z</lastmod><news:news><news:publication_date>2026-05-16T18:19:43.654Z</news:publication_date>
        <news:title><![CDATA[Aglatimagene plus radiotherapy improves prostate cancer-specific DFS ]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.urologytimes.com/view/phenotype-guided-management-is-key-to-treating-nocturia-in-older-patients</loc><lastmod>2026-05-16T17:51:57.387Z</lastmod><news:news><news:publication_date>2026-05-16T17:51:57.387Z</news:publication_date>
        <news:title><![CDATA[Phenotype-guided management is key to treating nocturia in older patients]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.urologytimes.com/view/community-engagement-drives-unc-s-effort-to-close-prostate-cancer-care-gaps</loc><lastmod>2026-05-16T13:56:49.791Z</lastmod><news:news><news:publication_date>2026-05-16T13:56:49.791Z</news:publication_date>
        <news:title><![CDATA[Community engagement drives UNC's effort to close prostate cancer care gaps]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.urologytimes.com/view/the-uroonc-minute-cystectomy-vs-bladder-sparing-therapy-with-mary-beth-westerman-md-facs</loc><lastmod>2026-05-16T12:00:00Z</lastmod><news:news><news:publication_date>2026-05-16T12:00:00Z</news:publication_date>
        <news:title><![CDATA[The UroOnc Minute: Cystectomy vs Bladder-Sparing Therapy, with Mary Beth Westerman, MD, FACS]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.urologytimes.com/view/aua-2026-expanded-potomac-analyses-support-durvalumab-plus-bcg</loc><lastmod>2026-05-15T22:32:08.847Z</lastmod><news:news><news:publication_date>2026-05-15T22:32:08.847Z</news:publication_date>
        <news:title><![CDATA[AUA 2026: Expanded POTOMAC analyses support durvalumab plus BCG]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.urologytimes.com/view/arasec-darolutamide-plus-adt-reduces-progression-risk-in-mhspc</loc><lastmod>2026-05-15T20:34:04.579Z</lastmod><news:news><news:publication_date>2026-05-15T20:34:04.579Z</news:publication_date>
        <news:title><![CDATA[ARASEC: Darolutamide plus ADT reduces progression risk in mHSPC]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.urologytimes.com/view/fda-approves-atezolizumab-as-adjuvant-therapy-for-mibc-guided-by-ctdna</loc><lastmod>2026-05-15T19:03:22.648Z</lastmod><news:news><news:publication_date>2026-05-15T19:03:22.648Z</news:publication_date>
        <news:title><![CDATA[FDA approves atezolizumab as adjuvant therapy for MIBC guided by ctDNA]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.urologytimes.com/view/perioperative-durvalumab-plus-enfortumab-vedotin-improves-efs-in-cisplatin-ineligible-mibc</loc><lastmod>2026-05-14T14:05:00Z</lastmod><news:news><news:publication_date>2026-05-14T14:05:00Z</news:publication_date>
        <news:title><![CDATA[Perioperative durvalumab plus enfortumab vedotin improves EFS in cisplatin-ineligible MIBC]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.urologytimes.com/view/pearls-perspectives-rethinking-pelvic-pain-and-bladder-health-with-heather-florio</loc><lastmod>2026-05-14T14:00:00Z</lastmod><news:news><news:publication_date>2026-05-14T14:00:00Z</news:publication_date>
        <news:title><![CDATA[Pearls & Perspectives: Rethinking Pelvic Pain and Bladder Health, with Heather Florio]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.urologytimes.com/view/study-psadt-is-often-undocumented-in-high-risk-biochemical-recurrence</loc><lastmod>2026-05-14T12:00:00Z</lastmod><news:news><news:publication_date>2026-05-14T12:00:00Z</news:publication_date>
        <news:title><![CDATA[Study: PSADT is often undocumented in high-risk biochemical recurrence]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.urologytimes.com/view/aua-2026-preview-practice-changing-trials-in-benign-urology</loc><lastmod>2026-05-13T16:35:39.927Z</lastmod><news:news><news:publication_date>2026-05-13T16:35:39.927Z</news:publication_date>
        <news:title><![CDATA[AUA 2026 preview: Practice-changing trials in benign urology]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.urologytimes.com/view/fda-grants-clearance-to-total-testosterone-assay</loc><lastmod>2026-05-13T14:32:08.083Z</lastmod><news:news><news:publication_date>2026-05-13T14:32:08.083Z</news:publication_date>
        <news:title><![CDATA[FDA grants clearance to total testosterone assay]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.urologytimes.com/view/savitha-krishnan-md-discusses-patient-selection-for-robotic-sacrocolpopexy</loc><lastmod>2026-05-13T14:22:14.506Z</lastmod><news:news><news:publication_date>2026-05-13T14:22:14.506Z</news:publication_date>
        <news:title><![CDATA[Savitha Krishnan, MD, discusses patient selection for robotic sacrocolpopexy]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.urologytimes.com/view/aua-2026-preview-practice-changing-trials-in-urologic-oncology</loc><lastmod>2026-05-12T20:06:58.345Z</lastmod><news:news><news:publication_date>2026-05-12T20:06:58.345Z</news:publication_date>
        <news:title><![CDATA[AUA 2026 preview: Practice-changing trials in urologic oncology]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.urologytimes.com/view/matthew-nielsen-md-ms-facs-previews-key-themes-at-the-2026-aua-annual-meeting</loc><lastmod>2026-05-12T17:27:41.974Z</lastmod><news:news><news:publication_date>2026-05-12T17:27:41.974Z</news:publication_date>
        <news:title><![CDATA[Matthew Nielsen, MD, MS, FACS, previews key themes at the 2026 AUA Annual Meeting]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.urologytimes.com/view/isaac-kim-md-on-advances-driving-the-future-of-prostate-cancer-outcomes</loc><lastmod>2026-05-12T16:30:00Z</lastmod><news:news><news:publication_date>2026-05-12T16:30:00Z</news:publication_date>
        <news:title><![CDATA[Isaac Kim, MD, on advances driving the future of prostate cancer outcomes]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.urologytimes.com/view/decision-making-for-bph-in-the-mists-era</loc><lastmod>2026-05-12T12:00:00Z</lastmod><news:news><news:publication_date>2026-05-12T12:00:00Z</news:publication_date>
        <news:title><![CDATA[Decision-Making for BPH in the MISTs Era]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.urologytimes.com/view/resident-perspective-yeonsoo-sara-lee-md-discusses-top-priorities-at-aua-2026</loc><lastmod>2026-05-11T19:30:24.054Z</lastmod><news:news><news:publication_date>2026-05-11T19:30:24.054Z</news:publication_date>
        <news:title><![CDATA[Resident perspective: Yeonsoo Sara Lee, MD, discusses top priorities at AUA 2026]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.urologytimes.com/view/edison-histotripsy-system-submitted-to-fda-for-kidney-tumor-indication</loc><lastmod>2026-05-11T17:45:00Z</lastmod><news:news><news:publication_date>2026-05-11T17:45:00Z</news:publication_date>
        <news:title><![CDATA[Edison Histotripsy System submitted to FDA for kidney tumor indication]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.urologytimes.com/view/fda-grants-de-novo-authorization-to-aurie-reusable-intermittent-catheter-system</loc><lastmod>2026-05-11T14:40:00Z</lastmod><news:news><news:publication_date>2026-05-11T14:40:00Z</news:publication_date>
        <news:title><![CDATA[FDA grants de novo authorization to Aurie Reusable Intermittent Catheter System]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.urologytimes.com/view/expanding-access-to-bladder-cancer-detection-tools</loc><lastmod>2026-05-08T18:20:00Z</lastmod><news:news><news:publication_date>2026-05-08T18:20:00Z</news:publication_date>
        <news:title><![CDATA[Expanding Access to Bladder Cancer Detection Tools]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.urologytimes.com/view/reassessing-cis-in-bcg-unresponsive-disease</loc><lastmod>2026-05-08T18:15:00Z</lastmod><news:news><news:publication_date>2026-05-08T18:15:00Z</news:publication_date>
        <news:title><![CDATA[Reassessing CIS in BCG-Unresponsive Disease]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.urologytimes.com/view/cis-detection-shared-responsibility-in-nmibc-care</loc><lastmod>2026-05-08T17:40:00Z</lastmod><news:news><news:publication_date>2026-05-08T17:40:00Z</news:publication_date>
        <news:title><![CDATA[CIS Detection: Shared Responsibility in NMIBC Care]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.urologytimes.com/view/why-cis-reporting-matters-in-bladder-cancer-care</loc><lastmod>2026-05-08T17:20:00Z</lastmod><news:news><news:publication_date>2026-05-08T17:20:00Z</news:publication_date>
        <news:title><![CDATA[Why CIS Reporting Matters in Bladder Cancer Care]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.urologytimes.com/view/the-uroonc-minute-emergency-hematuria-management-with-nikita-r-bhatt-mbbs-mch-mmed-frcs</loc><lastmod>2026-05-08T10:00:00Z</lastmod><news:news><news:publication_date>2026-05-08T10:00:00Z</news:publication_date>
        <news:title><![CDATA[The UroOnc Minute: Emergency Hematuria Management, with Nikita R. Bhatt, MBBS, MCh, MMed, FRCS]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.urologytimes.com/view/fda-clears-glean-abdominal-sensor-expanding-catheter-free-urodynamics-platform</loc><lastmod>2026-05-07T15:40:00Z</lastmod><news:news><news:publication_date>2026-05-07T15:40:00Z</news:publication_date>
        <news:title><![CDATA[FDA clears Glean Abdominal Sensor, expanding catheter-free urodynamics platform]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.urologytimes.com/view/precision-escalation-may-define-the-future-of-high-risk-nmibc-care</loc><lastmod>2026-05-07T14:20:00Z</lastmod><news:news><news:publication_date>2026-05-07T14:20:00Z</news:publication_date>
        <news:title><![CDATA[Precision escalation may define the future of high-risk NMIBC care]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.urologytimes.com/view/integrating-evidence-and-identifying-future-research-needs-in-metastatic-castration-sensitive-prostate-cancer-mcspc-</loc><lastmod>2026-05-07T12:05:00Z</lastmod><news:news><news:publication_date>2026-05-07T12:05:00Z</news:publication_date>
        <news:title><![CDATA[Integrating Evidence and Identifying Future Research Needs in Metastatic Castration Sensitive Prostate Cancer (mCSPC) ]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.urologytimes.com/view/evaluating-observational-and-propensity-matched-studies-in-metastatic-castration-sensitive-prostate-cancer-mcspc-</loc><lastmod>2026-05-07T12:00:00Z</lastmod><news:news><news:publication_date>2026-05-07T12:00:00Z</news:publication_date>
        <news:title><![CDATA[Evaluating Observational and Propensity Matched Studies in Metastatic Castration Sensitive Prostate Cancer (mCSPC)]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.urologytimes.com/view/charles-powell-md-highlights-neuspera-system-s-12-month-uui-outcomes</loc><lastmod>2026-05-06T18:50:00Z</lastmod><news:news><news:publication_date>2026-05-06T18:50:00Z</news:publication_date>
        <news:title><![CDATA[Charles Powell, MD, highlights Neuspera System’s 12-month UUI outcomes]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.urologytimes.com/view/bladder-cancer-awareness-month-the-rise-of-biomarkers-and-precision-care</loc><lastmod>2026-05-06T16:50:02.824Z</lastmod><news:news><news:publication_date>2026-05-06T16:50:02.824Z</news:publication_date>
        <news:title><![CDATA[Bladder Cancer Awareness Month: The rise of biomarkers and precision care]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.urologytimes.com/view/mps2-as-outperforms-mpmri-for-prostate-cancer-upgrading-during-active-surveillance</loc><lastmod>2026-05-06T14:45:50.852Z</lastmod><news:news><news:publication_date>2026-05-06T14:45:50.852Z</news:publication_date>
        <news:title><![CDATA[MPS2-AS outperforms mpMRI for prostate cancer upgrading during active surveillance ]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.urologytimes.com/view/integrating-psma-pet-into-clinical-practice-in-advanced-prostate-cancer</loc><lastmod>2026-05-06T13:27:35.789Z</lastmod><news:news><news:publication_date>2026-05-06T13:27:35.789Z</news:publication_date>
        <news:title><![CDATA[Integrating PSMA PET into Clinical Practice in Advanced Prostate Cancer]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.urologytimes.com/view/comparative-psma-pet-tracer-performance-in-advanced-prostate-cancer</loc><lastmod>2026-05-06T13:22:29.147Z</lastmod><news:news><news:publication_date>2026-05-06T13:22:29.147Z</news:publication_date>
        <news:title><![CDATA[Comparative PSMA PET Tracer Performance in Advanced Prostate Cancer]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.urologytimes.com/view/martin-gleave-md-on-biomarker-driven-neoadjuvant-strategies-in-prostate-cancer</loc><lastmod>2026-05-05T18:30:00Z</lastmod><news:news><news:publication_date>2026-05-05T18:30:00Z</news:publication_date>
        <news:title><![CDATA[Martin Gleave, MD, on biomarker-driven neoadjuvant strategies in prostate cancer]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.urologytimes.com/view/morcellator-safety-in-holep-owning-the-checklist-and-recognizing-early-warning-signs</loc><lastmod>2026-05-05T18:14:09.127Z</lastmod><news:news><news:publication_date>2026-05-05T18:14:09.127Z</news:publication_date>
        <news:title><![CDATA[Morcellator safety in HoLEP: Owning the checklist and recognizing early warning signs]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.urologytimes.com/view/gem-doce-maintenance-shows-comparable-outcomes-to-bcg-in-nmibc</loc><lastmod>2026-05-05T15:30:00Z</lastmod><news:news><news:publication_date>2026-05-05T15:30:00Z</news:publication_date>
        <news:title><![CDATA[Gem/Doce maintenance shows comparable outcomes to BCG in NMIBC]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.urologytimes.com/view/the-minimally-invasive-era-for-bph-an-overview-of-the-landscape</loc><lastmod>2026-05-05T12:00:00Z</lastmod><news:news><news:publication_date>2026-05-05T12:00:00Z</news:publication_date>
        <news:title><![CDATA[The Minimally Invasive Era for BPH: An Overview of the Landscape]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.urologytimes.com/view/bladder-cancer-awareness-month-emerging-therapies-and-evolving-standards-of-care</loc><lastmod>2026-05-04T18:30:00Z</lastmod><news:news><news:publication_date>2026-05-04T18:30:00Z</news:publication_date>
        <news:title><![CDATA[Bladder Cancer Awareness Month: Emerging therapies and evolving standards of care]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.urologytimes.com/view/jennifer-miles-thomas-md-shares-strategies-to-retain-apps-in-urology</loc><lastmod>2026-05-04T15:30:00Z</lastmod><news:news><news:publication_date>2026-05-04T15:30:00Z</news:publication_date>
        <news:title><![CDATA[Jennifer Miles-Thomas, MD, shares strategies to retain APPs in urology]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.urologytimes.com/view/fda-updates-in-urology-april-2026</loc><lastmod>2026-05-01T18:50:00Z</lastmod><news:news><news:publication_date>2026-05-01T18:50:00Z</news:publication_date>
        <news:title><![CDATA[FDA updates in urology: April 2026]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.urologytimes.com/view/the-uroonc-minute-biomarkers-for-penile-cancer-with-maarten-albersen-md-phd</loc><lastmod>2026-05-01T16:45:00Z</lastmod><news:news><news:publication_date>2026-05-01T16:45:00Z</news:publication_date>
        <news:title><![CDATA[The UroOnc Minute: Biomarkers for Penile Cancer, with Maarten Albersen, MD, PhD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.urologytimes.com/view/adanma-ayanambakkam-md-on-darlifarnib-cabozantinib-activity-in-ccrcc</loc><lastmod>2026-05-01T15:05:10.542Z</lastmod><news:news><news:publication_date>2026-05-01T15:05:10.542Z</news:publication_date>
        <news:title><![CDATA[Adanma Ayanambakkam, MD, on darlifarnib/cabozantinib activity in ccRCC]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.urologytimes.com/view/personalizing-long-term-treatment-of-metastatic-castration-sensitive-prostate-cancer</loc><lastmod>2026-05-01T12:15:00Z</lastmod><news:news><news:publication_date>2026-05-01T12:15:00Z</news:publication_date>
        <news:title><![CDATA[Personalizing Long-Term Treatment of Metastatic Castration-Sensitive Prostate Cancer]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.urologytimes.com/view/managing-fatigue-with-arpis-in-metastatic-castration-sensitive-prostate-cancer-in-the-clinic</loc><lastmod>2026-05-01T12:00:00Z</lastmod><news:news><news:publication_date>2026-05-01T12:00:00Z</news:publication_date>
        <news:title><![CDATA[Managing Fatigue with ARPIs in Metastatic Castration-Sensitive Prostate Cancer in the Clinic ]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.urologytimes.com/view/song-jiang-md-on-biomarker-driven-strategies-in-nmibc</loc><lastmod>2026-05-01T02:37:30.143Z</lastmod><news:news><news:publication_date>2026-05-01T02:37:30.143Z</news:publication_date>
        <news:title><![CDATA[Song Jiang, MD, on biomarker-driven strategies in NMIBC]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.urologytimes.com/view/expert-weighs-the-evolving-landscape-of-bcg-ici-combinations-in-nmibc</loc><lastmod>2026-05-01T01:53:19.436Z</lastmod><news:news><news:publication_date>2026-05-01T01:53:19.436Z</news:publication_date>
        <news:title><![CDATA[Expert weighs the potential role for BCG/ICI combinations in NMIBC]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.urologytimes.com/view/fda-odac-votes-in-favor-of-risk-benefit-profile-for-capivasertib-plus-abiraterone-in-pten-deficient-mhspc</loc><lastmod>2026-04-30T21:01:35.500Z</lastmod><news:news><news:publication_date>2026-04-30T21:01:35.500Z</news:publication_date>
        <news:title><![CDATA[FDA ODAC votes in favor of capivasertib plus abiraterone in PTEN-deficient mHSPC]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.urologytimes.com/view/salvage-hifu-demonstrates-encouraging-mid-term-outcomes-in-radiorecurrent-prostate-cancer</loc><lastmod>2026-04-30T15:45:00Z</lastmod><news:news><news:publication_date>2026-04-30T15:45:00Z</news:publication_date>
        <news:title><![CDATA[Salvage HIFU demonstrates encouraging mid-term outcomes in radiorecurrent prostate cancer]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.urologytimes.com/view/charles-powell-md-on-glp-1-use-and-sacral-neuromodulation-outcomes</loc><lastmod>2026-04-30T14:00:00Z</lastmod><news:news><news:publication_date>2026-04-30T14:00:00Z</news:publication_date>
        <news:title><![CDATA[Charles Powell, MD, on GLP-1 use and sacral neuromodulation outcomes]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.urologytimes.com/view/using-real-world-evidence-to-guide-treatment-decisions-in-metastatic-castration-sensitive-prostate-cancer-mcspc-</loc><lastmod>2026-04-30T12:05:00Z</lastmod><news:news><news:publication_date>2026-04-30T12:05:00Z</news:publication_date>
        <news:title><![CDATA[Using Real World Evidence to Guide Treatment Decisions in Metastatic Castration Sensitive Prostate Cancer (mCSPC)]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.urologytimes.com/view/interpreting-subgroup-analyses-and-real-world-evidence-in-metastatic-castration-sensitive-prostate-cancer-mcspc-</loc><lastmod>2026-04-30T12:00:00Z</lastmod><news:news><news:publication_date>2026-04-30T12:00:00Z</news:publication_date>
        <news:title><![CDATA[Interpreting Subgroup Analyses and Real World Evidence in Metastatic Castration Sensitive Prostate Cancer (mCSPC)]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.urologytimes.com/view/akanksha-mehta-md-on-counseling-patients-on-fertility-after-vasectomy</loc><lastmod>2026-04-29T18:15:00Z</lastmod><news:news><news:publication_date>2026-04-29T18:15:00Z</news:publication_date>
        <news:title><![CDATA[Akanksha Mehta, MD, on counseling patients on fertility after vasectomy]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.urologytimes.com/view/testicular-cancer-awareness-month-eau-guideline-faqs-for-urologists</loc><lastmod>2026-04-29T16:35:00Z</lastmod><news:news><news:publication_date>2026-04-29T16:35:00Z</news:publication_date>
        <news:title><![CDATA[Testicular Cancer Awareness Month: EAU Guideline FAQs for Urologists]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.urologytimes.com/view/adanma-ayanambakkam-md-ms-highlights-safety-profile-of-darlifarnib-cabozantinib-in-ccrcc</loc><lastmod>2026-04-29T13:20:00Z</lastmod><news:news><news:publication_date>2026-04-29T13:20:00Z</news:publication_date>
        <news:title><![CDATA[Adanma Ayanambakkam, MD, MS, highlights safety profile of darlifarnib/cabozantinib in ccRCC]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.urologytimes.com/view/clinical-use-of-psma-pet-in-advanced-prostate-cancer</loc><lastmod>2026-04-29T12:05:00Z</lastmod><news:news><news:publication_date>2026-04-29T12:05:00Z</news:publication_date>
        <news:title><![CDATA[Clinical Use of PSMA PET in Advanced Prostate Cancer]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.urologytimes.com/view/impact-of-psma-pet-on-treatment-selection-in-advanced-prostate-cancer</loc><lastmod>2026-04-29T12:00:00Z</lastmod><news:news><news:publication_date>2026-04-29T12:00:00Z</news:publication_date>
        <news:title><![CDATA[Impact of PSMA PET on Treatment Selection in Advanced Prostate Cancer]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.urologytimes.com/view/helen-bernie-do-discusses-potential-trt-label-expansion-for-idiopathic-hypogonadism</loc><lastmod>2026-04-28T17:05:00Z</lastmod><news:news><news:publication_date>2026-04-28T17:05:00Z</news:publication_date>
        <news:title><![CDATA[Helen Bernie, DO, discusses potential TRT label expansion for idiopathic hypogonadism]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.urologytimes.com/view/fda-greenlights-trial-of-needle-free-drug-delivery-system-for-overactive-bladder</loc><lastmod>2026-04-28T14:15:00Z</lastmod><news:news><news:publication_date>2026-04-28T14:15:00Z</news:publication_date>
        <news:title><![CDATA[FDA green lights trial of needle-free drug delivery system for overactive bladder]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.urologytimes.com/view/nannan-thirumavalavan-md-reflects-on-1-year-of-fda-testosterone-labeling-changes</loc><lastmod>2026-04-27T19:40:39.273Z</lastmod><news:news><news:publication_date>2026-04-27T19:40:39.273Z</news:publication_date>
        <news:title><![CDATA[Nannan Thirumavalavan, MD, reflects on 1 year of FDA testosterone labeling changes]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.urologytimes.com/view/daniel-george-md-on-the-importance-of-caregivers-in-metastatic-prostate-cancer-care</loc><lastmod>2026-04-27T16:30:00Z</lastmod><news:news><news:publication_date>2026-04-27T16:30:00Z</news:publication_date>
        <news:title><![CDATA[Daniel George, MD, on the importance of caregivers in metastatic prostate cancer care]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.urologytimes.com/view/sacituzumab-govitecan-pembrolizumab-achieves-promising-cr-rate-in-mibc</loc><lastmod>2026-04-27T15:30:00Z</lastmod><news:news><news:publication_date>2026-04-27T15:30:00Z</news:publication_date>
        <news:title><![CDATA[Sacituzumab govitecan/pembrolizumab achieves promising CR rate in MIBC]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.urologytimes.com/view/dalia-kaakour-md-mph-on-ctdna-in-testicular-cancer-surveillance</loc><lastmod>2026-04-24T18:20:00Z</lastmod><news:news><news:publication_date>2026-04-24T18:20:00Z</news:publication_date>
        <news:title><![CDATA[Dalia Kaakour, MD, MPH, on ctDNA in testicular cancer surveillance]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.urologytimes.com/view/financial-toxicity-diagnostic-delays-remain-challenges-in-bladder-cancer</loc><lastmod>2026-04-24T17:00:00Z</lastmod><news:news><news:publication_date>2026-04-24T17:00:00Z</news:publication_date>
        <news:title><![CDATA[Financial toxicity, diagnostic delays remain challenges in bladder cancer]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.urologytimes.com/view/the-uroonc-minute-pelvic-lymph-node-dissection-during-radical-prostatectomy-with-giorgio-gandaglia-md</loc><lastmod>2026-04-24T15:10:21.114Z</lastmod><news:news><news:publication_date>2026-04-24T15:10:21.114Z</news:publication_date>
        <news:title><![CDATA[The UroOnc Minute: Pelvic Lymph Node Dissection During Radical Prostatectomy, with Giorgio Gandaglia, MD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.urologytimes.com/view/multidisciplinary-interpretation-of-psma-pet-in-advanced-prostate-cancer</loc><lastmod>2026-04-24T13:41:14.101Z</lastmod><news:news><news:publication_date>2026-04-24T13:41:14.101Z</news:publication_date>
        <news:title><![CDATA[Multidisciplinary Interpretation of PSMA PET in Advanced Prostate Cancer]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.urologytimes.com/view/limitations-of-conventional-imaging-in-advanced-prostate-cancer</loc><lastmod>2026-04-24T13:39:55.831Z</lastmod><news:news><news:publication_date>2026-04-24T13:39:55.831Z</news:publication_date>
        <news:title><![CDATA[Limitations of Conventional Imaging in Advanced Prostate Cancer]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.urologytimes.com/view/the-treatment-of-bph-before-minimally-invasive-options</loc><lastmod>2026-04-24T12:00:00Z</lastmod><news:news><news:publication_date>2026-04-24T12:00:00Z</news:publication_date>
        <news:title><![CDATA[The Treatment of BPH Before Minimally Invasive Options]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.urologytimes.com/view/fractionated-225ac-j591-shows-early-activity-preserved-qol-in-mcrpc</loc><lastmod>2026-04-23T18:50:00Z</lastmod><news:news><news:publication_date>2026-04-23T18:50:00Z</news:publication_date>
        <news:title><![CDATA[Fractionated 225Ac–J591 shows early activity, preserved QOL in mCRPC]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.urologytimes.com/view/dinesh-singh-md-on-how-suction-enabled-urs-and-ai-are-poised-to-transform-stone-management</loc><lastmod>2026-04-23T16:42:49.204Z</lastmod><news:news><news:publication_date>2026-04-23T16:42:49.204Z</news:publication_date>
        <news:title><![CDATA[Dinesh Singh, MD, on how suction-enabled URS and AI are poised to transform stone management]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.urologytimes.com/view/applying-clinical-trial-data-to-real-world-patients-in-metastatic-castration-sensitive-prostate-cancer-mcspc-</loc><lastmod>2026-04-23T12:05:00Z</lastmod><news:news><news:publication_date>2026-04-23T12:05:00Z</news:publication_date>
        <news:title><![CDATA[Applying Clinical Trial Data to Real World Patients in Metastatic Castration Sensitive Prostate Cancer (mCSPC) ]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.urologytimes.com/view/individualizing-ar-pathway-inhibitor-selection-in-metastatic-castration-sensitive-prostate-cancer-mcspc-</loc><lastmod>2026-04-23T12:00:00Z</lastmod><news:news><news:publication_date>2026-04-23T12:00:00Z</news:publication_date>
        <news:title><![CDATA[Individualizing AR Pathway Inhibitor Selection in Metastatic Castration Sensitive Prostate Cancer (mCSPC)]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.urologytimes.com/view/david-wise-md-on-the-potential-role-for-pasritamig-plus-docetaxel-in-mcrpc</loc><lastmod>2026-04-23T12:00:00Z</lastmod><news:news><news:publication_date>2026-04-23T12:00:00Z</news:publication_date>
        <news:title><![CDATA[David Wise, MD, on the potential role for pasritamig plus docetaxel in mCRPC]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.urologytimes.com/view/preclinical-data-show-potential-of-cd46-targeted-combination-therapy-in-prostate-cancer</loc><lastmod>2026-04-22T20:00:44.787Z</lastmod><news:news><news:publication_date>2026-04-22T20:00:44.787Z</news:publication_date>
        <news:title><![CDATA[Preclinical data show potential of CD46-targeted combination therapy in prostate cancer]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.urologytimes.com/view/cabozantinib-plus-nivolumab-shows-encouraging-activity-in-mcrpc</loc><lastmod>2026-04-22T17:20:34.628Z</lastmod><news:news><news:publication_date>2026-04-22T17:20:34.628Z</news:publication_date>
        <news:title><![CDATA[Cabozantinib plus nivolumab shows encouraging activity in mCRPC]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.urologytimes.com/view/when-should-post-vasectomy-semen-analysis-be-performed-</loc><lastmod>2026-04-22T14:55:00Z</lastmod><news:news><news:publication_date>2026-04-22T14:55:00Z</news:publication_date>
        <news:title><![CDATA[When should post-vasectomy semen analysis be performed?]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.urologytimes.com/view/eau-2026-testicular-cancer-guideline-reflects-key-updates-in-diagnosis-and-management</loc><lastmod>2026-04-21T17:30:50.696Z</lastmod><news:news><news:publication_date>2026-04-21T17:30:50.696Z</news:publication_date>
        <news:title><![CDATA[EAU 2026 Testicular Cancer Guideline reflects key updates in diagnosis and management]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.urologytimes.com/view/neha-vapiwala-md-on-intensifying-radiotherapy-in-prostate-cancer</loc><lastmod>2026-04-21T15:00:00Z</lastmod><news:news><news:publication_date>2026-04-21T15:00:00Z</news:publication_date>
        <news:title><![CDATA[Neha Vapiwala, MD, on intensifying radiotherapy in prostate cancer]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.urologytimes.com/view/litespark-012-trial-misses-dual-primary-end-points-in-advanced-ccrcc</loc><lastmod>2026-04-21T12:55:00Z</lastmod><news:news><news:publication_date>2026-04-21T12:55:00Z</news:publication_date>
        <news:title><![CDATA[LITESPARK-012 trial misses dual primary end points in advanced ccRCC]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.urologytimes.com/view/operational-best-practices-to-improve-access-in-mcrpc</loc><lastmod>2026-04-21T12:30:00Z</lastmod><news:news><news:publication_date>2026-04-21T12:30:00Z</news:publication_date>
        <news:title><![CDATA[Operational Best Practices To Improve Access in mCRPC]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.urologytimes.com/view/psma-targeted-t-cell-engager-enters-phase-1-testing-in-mcrpc</loc><lastmod>2026-04-20T18:30:00Z</lastmod><news:news><news:publication_date>2026-04-20T18:30:00Z</news:publication_date>
        <news:title><![CDATA[PSMA-targeted T-cell engager enters phase 1 testing in mCRPC ]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.urologytimes.com/view/darlifarnib-plus-cabozantinib-shows-early-activity-in-ccrcc</loc><lastmod>2026-04-20T16:30:00Z</lastmod><news:news><news:publication_date>2026-04-20T16:30:00Z</news:publication_date>
        <news:title><![CDATA[Darlifarnib plus cabozantinib shows early activity in ccRCC]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url></urlset>